EULAR® 2024 Insights


 

EULAR® 2024 Insights- Implications of Newly Established Malignancy Screening Guidelines for Idiopathic Inflammatory Myopathies: A Multicenter, International Evaluation of Clinical and Economic Impact by the Myositis Audit and Research Collaborative Group

0 views
July 24, 2024
Comments 0
Login to view comments. Click here to Login